These final results, together with a previous report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 assist the thought of concentrating on ACKR3 as a novel method to modulate the opioid technique, which could open new therapeutic avenues for opioid-associated disorders. Importantly, these receptors were https://sandrav505vxw5.vidublog.com/profile